Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Consumption and expenditure of the reference biological product of infliximab® (Remicade®) and two of its biosimilar products (Inflectra® and Remsima™), Norway, 2008-2016
NOK: Norwegian krone.
Notes: Consumption is defined as daily doses per 1000 inhabitants. A defined daily dose (DDD) is the assumed average maintenance dose for the main indication of the medicine in adults. For inflixmab it corresponds to 3.75 mg per day.3
Source: Based on data from Farmastat Norway.
